CRESEMBA (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the CRESEMBA drug offered from Astellas Pharma US, Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
| NON-PROPRIETARY NAME: | isavuconazonium sulfate |
| SUBSTANCE NAME: | ISAVUCONAZONIUM SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-03-06 |
| END MARKETING DATE: | 0000-00-00 |
CRESEMBA HUMAN PRESCRIPTION DRUG Details:
| Item Description | CRESEMBA from Astellas Pharma US, Inc. |
| LABELER NAME: | Astellas Pharma US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 74.4(mg/mL) |
| START MARKETING DATE: | 2015-03-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0469-0420_f988c363-dca8-4ab7-b675-beae85041472 |
| PRODUCT NDC: | 0469-0420 |
| APPLICATION NUMBER: | NDA207501 |
Other ISAVUCONAZONIUM SULFATE Pharmaceutical Manufacturers / Labelers:
